FDA approves first competitive generic therapy drug
09-08-2018
ca-ssis / iStockphoto.com
The US Food and Drug Administration (FDA) has published new draft guidance on a pathway intended to boost the development of generics and lower drug prices.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
US Food and Drug Administration, competitive generic therapies, market exclusivity, abbreviated new drug application, Scott Gottlieb
